{
    "organizations": [],
    "uuid": "e13913c64ed1e6f9d2b900b22691e953ddee18d5",
    "author": "",
    "url": "https://www.reuters.com/article/brief-novocure-reports-positive-top-line/brief-novocure-reports-positive-top-line-results-from-stellar-phase-2-pilot-trial-in-mesothelioma-idUSASO0003DD",
    "ord_in_thread": 0,
    "title": "BRIEF-Novocure Reports Positive Top-Line Results From Stellar Phase 2 Pilot Trial In Mesothelioma",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 17, 2018 / 2:08 PM / Updated 30 minutes ago BRIEF-Novocure Reports Positive Top-Line Results From Stellar Phase 2 Pilot Trial In Mesothelioma Reuters Staff \nApril 17 (Reuters) - Novocure Ltd: \n* NOVOCURE REPORTS POSITIVE TOP-LINE RESULTS FROM STELLAR PHASE 2 PILOT TRIAL IN MESOTHELIOMA \n* NOVOCURE LTD - FINAL STELLAR DATA EXCEEDED RESULTS OF INTERIM ANALYSIS FOR ALL EFFICACY ENDPOINTS \n* NOVOCURE LTD - NOVOCURE PLANS TO SUBMIT A HUMANITARIAN DEVICE EXEMPTION APPLICATION TO FDA FOR APPROVAL Source text for Eikon: Further company coverage:",
    "published": "2018-04-17T17:05:00.000+03:00",
    "crawled": "2018-04-17T17:46:08.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "pm",
        "updated",
        "minute",
        "ago",
        "report",
        "positive",
        "result",
        "stellar",
        "phase",
        "pilot",
        "trial",
        "mesothelioma",
        "reuters",
        "staff",
        "april",
        "reuters",
        "novocure",
        "ltd",
        "novocure",
        "report",
        "positive",
        "result",
        "stellar",
        "phase",
        "pilot",
        "trial",
        "mesothelioma",
        "novocure",
        "ltd",
        "final",
        "stellar",
        "data",
        "exceeded",
        "result",
        "interim",
        "analysis",
        "efficacy",
        "endpoint",
        "novocure",
        "ltd",
        "novocure",
        "plan",
        "submit",
        "humanitarian",
        "device",
        "exemption",
        "application",
        "fda",
        "approval",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}